Tag: Pharma
Pfizer INDovation awards grants of over ₹8 Crore to 14 Indian...
In partnership with DPIIT, Department of Pharmaceuticals and NITI Aayog, the INDovation program provides MedTech startups with clinical and regulatory support, or deployment support in select Ayushman Arogya Mandirs in Maharashtra
Zydus Lifesciences reports strong Q3 and 9M FY26 financial performance
In Q3 FY26, revenue from operations rose 30% year-on-year to ₹68,645 million, while EBITDA grew 31% to ₹18,164 million, with margins improving to 26.5%
Shukra Pharma gets ~₹600 Cr facility from YEIDA for surgical robotics,...
Partnership introduces AI-driven Veer Surgical Robot, marking a significant step toward affordable, accessible robotic surgery across India and Asia
Emcure posts strong Q3FY26 results with ₹2,363 crore & 20.4 %...
The company's domestic business recorded sales of ₹1,025 crore, up 15.4 percent year-on-year
CM Yogi Adityanath to pharma industry: “Come, invest, produce and receive...
The Chief Minister of Uttar Pradesh inaugurated the global congregation of investors and entrepreneurs 'Uttar Pradesh Pharma Conclave 1.0' in Lucknow on February 03, 2026
Budget 2026: OPPI calls ‘Biopharma Shakti’ India’s leap toward global leadership
The Budget’s focused push on biologics and biosimilars, backed by a dedicated biopharma innovation network, was described by Matai as positioning India strongly for the next wave of complex, high-value therapies
AMTZ expands advanced additive manufacturing CoE to boost India’s MedTech component...
The Centre has worked with over 20 startups and 35 industry partners; providing end-to-end support ranging from industrial design and rapid prototyping to machining, post-processing and production
Beyond Trade: How the EU–India FTA reshapes life-sciences industry
The deal represents nearly 25% of global GDP and one-third of global trade, making it one of the most consequential trade agreements of this era
Health Minister J P Nadda releases 10th edition of Indian pharmacopoeia
Indian Pharmacopoeia 2026 expands coverage of anti-TB, anti-diabetic and anti-cancer medicines with 121 new monographs
Lupin signs exclusive licensing agreement with Gan & Lee Pharmaceuticals for...
The agreement strengthens Lupin’s diabetes portfolio and accelerates its presence in the obesity segment